These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17395470)

  • 1. Differential receptor binding characteristics of consecutive phenylalanines in micro-opioid specific peptide ligand endomorphin-2.
    Honda T; Shirasu N; Isozaki K; Kawano M; Shigehiro D; Chuman Y; Fujita T; Nose T; Shimohigashi Y
    Bioorg Med Chem; 2007 Jun; 15(11):3883-8. PubMed ID: 17395470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of stereoisomeric analogues of endomorphin-2, H-Tyr-Pro-Phe-Phe-NH(2), and examination of their opioid receptor binding activities and solution conformation.
    Okada Y; Fukumizu A; Takahashi M; Shimizu Y; Tsuda Y; Yokoi T; Bryant SD; Lazarus LH
    Biochem Biophys Res Commun; 2000 Sep; 276(1):7-11. PubMed ID: 11006073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel highly potent mu-opioid receptor antagonist based on endomorphin-2 structure.
    Fichna J; do-Rego JC; Janecki T; Staniszewska R; Poels J; Broeck JV; Costentin J; Schiller PW; Janecka A
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1350-3. PubMed ID: 18207400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereochemical requirements for receptor recognition of the mu-opioid peptide endomorphin-1.
    Paterlini MG; Avitabile F; Ostrowski BG; Ferguson DM; Portoghese PS
    Biophys J; 2000 Feb; 78(2):590-9. PubMed ID: 10653774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel endomorphin-2 analogs with mu-opioid receptor antagonist activity.
    Kruszynski R; Fichna J; do-Rego JC; Chung NN; Schiller PW; Kosson P; Costentin J; Janecka A
    J Pept Res; 2005 Sep; 66(3):125-31. PubMed ID: 16083439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of new endomorphin-2 analogues containing (Z)-alpha,beta-didehydrophenylalanine (Delta(Z)Phe) residues.
    Torino D; Mollica A; Pinnen F; Feliciani F; Lucente G; Fabrizi G; Portalone G; Davis P; Lai J; Ma SW; Porreca F; Hruby VJ
    J Med Chem; 2010 Jun; 53(11):4550-4. PubMed ID: 20476738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational analysis of endomorphin-2 analogs with phenylalanine mimics by NMR and molecular modeling.
    Shao X; Gao Y; Zhu C; Liu X; Yao J; Cui Y; Wang R
    Bioorg Med Chem; 2007 May; 15(10):3539-47. PubMed ID: 17368034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low Energy Conformations for Endogenous Mu-Receptor-Specific Peptides.
    Lin B; Carty RP; Pincus MR
    Protein J; 2020 Jun; 39(3):217-223. PubMed ID: 32449111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular modeling studies to predict the possible binding modes of endomorphin analogs in mu opioid receptor.
    Liu X; Kai M; Jin L; Wang R
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5387-91. PubMed ID: 19679474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complex of an active mu-opioid receptor with a cyclic peptide agonist modeled from experimental constraints.
    Fowler CB; Pogozheva ID; Lomize AL; LeVine H; Mosberg HI
    Biochemistry; 2004 Dec; 43(50):15796-810. PubMed ID: 15595835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of relatively large amounts of endomorphin-1 and endomorphin-2 from human brain cortex.
    Hackler L; Zadina JE; Ge LJ; Kastin AJ
    Peptides; 1997; 18(10):1635-9. PubMed ID: 9437727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential roles of two consecutive phenylalanine residues in thrombin receptor-tethered ligand peptides (SFFLRNP) in thrombin receptor activation.
    Shimohigashi Y; Nose T; Okazaki M; Satoh Y; Ohno M; Costa T; Shimizu N; Ogino Y
    Biochem Biophys Res Commun; 1994 Aug; 203(1):366-72. PubMed ID: 8074680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel µ opioid antagonists derived from the µ opioid agonists endomorphin and [Dmt
    Shi S; Xu J; Feng L; Fan X; Chen Z; Qin Y; Chung NN; Li T; Schiller PW
    Chem Biol Drug Des; 2020 Nov; 96(5):1305-1314. PubMed ID: 32526055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and binding activity of endomorphin-1 analogues containing beta-amino acids.
    Cardillo G; Gentilucci L; Melchiorre P; Spampinato S
    Bioorg Med Chem Lett; 2000 Dec; 10(24):2755-8. PubMed ID: 11133084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake of radiolabelled endomorphins by experimental mammary adenocarcinoma.
    Wiercioch R; Mirowski M; Balcerczak E; Byszewska E; Wierzbicki R
    Nucl Med Rev Cent East Eur; 2005; 8(1):1-5. PubMed ID: 15977139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and evaluation of new endomorphin analogs with enhanced central antinociception after peripheral administration.
    Liu X; Zhao L; Wang Y; Mou L; Yang J; Zhang Y; Wang D; Wang R
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5393-7. PubMed ID: 26403932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inverse type II β-turn on D-Trp-Phe, a pharmacophoric motif for MOR agonists.
    Gentilucci L; Tolomelli A; De Marco R; Spampinato S; Bedini A; Artali R
    ChemMedChem; 2011 Sep; 6(9):1640-53. PubMed ID: 21721130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-methyl substitution of cyclohexylalanine in Dmt-Tic-Cha-Phe peptides results in highly potent delta opioid antagonists.
    Tóth G; Ioja E; Tömböly C; Ballet S; Tourwé D; Péter A; Martinek T; Chung NN; Schiller PW; Benyhe S; Borsodi A
    J Med Chem; 2007 Jan; 50(2):328-33. PubMed ID: 17228874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential mechanisms mediating descending pain controls for antinociception induced by supraspinally administered endomorphin-1 and endomorphin-2 in the mouse.
    Ohsawa M; Mizoguchi H; Narita M; Chu M; Nagase H; Tseng LF
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1106-11. PubMed ID: 10945866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endomorphin-1 analogues containing beta-proline are mu-opioid receptor agonists and display enhanced enzymatic hydrolysis resistance.
    Cardillo G; Gentilucci L; Qasem AR; Sgarzi F; Spampinato S
    J Med Chem; 2002 Jun; 45(12):2571-8. PubMed ID: 12036366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.